BioCentury
ARTICLE | Company News

EpiVax, Chugai deal

December 22, 2014 8:00 AM UTC

EpiVax granted Chugai rights to use EpiVax’s Interactive Protein Screening and Reengineering Interface (IPSRI) and OptiMatrix technologies to screen and develop therapeutic proteins. IPSRI is a cloud-...